Showing results (271-280 of 369) with videos related to

Sort By:
Pageof 37
Cancer Immunology, Immunotherapy : CII|April 28, 2025
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world studyYilin Wang, Shida Pan, Jiahe Tian, et al.
Frontiers in Immunology|August 15, 2020
HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ARTLu-Xue Zhang, Yan-Mei Jiao, Chao Zhang, et al.
Gastroenterology|May 6, 2008
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis BZheng Zhang, Ji-Yuan Zhang, E John Wherry, et al.
Chinese Journal of Integrative Medicine|March 31, 2006
Randomized double-blinded and controlled clinical trial on treatment of HIV/AIDS by Zhongyan-4Jian Wang, Feng-zhen Yang, Min Zhao, et al.
Cellular & Molecular Immunology|April 8, 2015
Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patientsXiangsheng Xu, Qinghua Shang, Xinyue Chen, et al.
European Journal of Immunology|April 17, 2013
Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis CJi-Yuan Zhang, Xiao-Li Wu, Bin Yang, et al.
Cell Discovery|December 10, 2020
Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patientsFeifei Yan, Fengming Huang, Jun Xu, et al.
Signal Transduction and Targeted Therapy|May 13, 2024
Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal studyHong-Hong Liu, Yunbo Xie, Bao-Peng Yang, et al.
Cell Metabolism|November 5, 2024
Non-invasive lipid panel of MASLD fibrosis transition underscores the role of lipoprotein sulfatides in hepatic immunomodulationSin Man Lam, Zehua Wang, Jin-Wen Song, et al.
BMJ Open|September 21, 2025
Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trialHongmin Wang, Xiaoying Li, Junfeng Lu, et al.
Pageof 37